Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV004825324 | SCV005445174 | uncertain significance | not specified | 2024-10-29 | criteria provided, single submitter | clinical testing | The c.133C>T (p.R45C) alteration is located in exon 3 (coding exon 2) of the MKNK2 gene. This alteration results from a C to T substitution at nucleotide position 133, causing the arginine (R) at amino acid position 45 to be replaced by a cysteine (C). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |